Análisis económico y de coste-beneficio de los tratamientos en cardiología. Enfoque en insuficiencia cardíaca

This publication has 19 references indexed in Scilit:

• Análisis coste-beneficio del uso de espironolactona en el tratamiento de la insuficiencia cardíaca crónica
  Revista Espanola de Cardiologia, 2001
• Evaluación económica de eptifibatide
  Revista Espanola de Cardiologia, 2001
• Ökonomische Bedeutung der Herzinsuffizienz Eine Übersicht der Kosten und der Wirtschaftlichkeit der Therapie
  Herz, 2000
• Resource Use and Survival of Patients Hospitalized with Congestive Heart Failure: Differences in Care by Specialty of the Attending Physician
  Annals of Internal Medicine, 2000
• Cost-effectiveness Analysis in Clinical Practice
  Archives of internal medicine (1960), 1999
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
  The Lancet, 1999
• Long-term survival in severe heart failure in patients treated with enalapril; ten year follow-up of CONSENSUS I
  European Heart Journal, 1999
• Impact of a nurse practitioner on the cost of managing inpatients with heart failure
  The American Journal of Cardiology, 1998
• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.
  Circulation, 1994